FREE SHIPPING with every SuperJeweler.com order! Shop Now
Published On: Sat, Dec 14th, 2019

Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug

Shares of Sarepta Therapeutics Inc soared 31% on Friday after U.S. regulators shocked Wall Street by approving the company’s treatment for a muscle-wasting disorder less than four months after rejecting the drug over safety concerns.


Reuters: Health News

FREE SHIPPING with every SuperJeweler.com order! Shop Now

About the Author

-

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Advertisements

Powered by WP Robot

Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug